Lévi F - Search Results

1

A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer.

Lévi F, Misset JL, Brienza S, Adam R, Metzger G, Itzakhi M, Caussanel JP, Kunstlinger F, Lecouturier S, Descorps-Declère A, et al. Lévi F, et al. Cancer. 1992 Feb 15;69(4):893-900. doi: 10.1002/1097-0142(19920215)69:4<893::aid-cncr2820690410>3.0.co;2-x. Cancer. 1992. PMID: 1735081 Clinical Trial.

2

[Biomedical bases of chronobiology].

Lévi F, Misset JL. Lévi F, et al. Soins. 1992 Nov;(566):10-1. Soins. 1992. PMID: 1290113 French. No abstract available.

3

A phase I trial of 21-day continuous venous infusion of alpha-interferon at circadian rhythm modulated rate in cancer patients.

Deprés-Brummer P, Levi F, Di Palma M, Beliard A, Lebon P, Marion S, Jasmin C, Misset JL. Deprés-Brummer P, et al. Among authors: levi f. J Immunother (1991). 1991 Dec;10(6):440-7. doi: 10.1097/00002371-199112000-00008. J Immunother (1991). 1991. PMID: 1768678

4

When should the immune clock be reset? From circadian pharmacodynamics to temporally optimized drug delivery.

Lévi F, Canon C, Dipalma M, Florentin I, Misset JL. Lévi F, et al. Ann N Y Acad Sci. 1991;618:312-29. doi: 10.1111/j.1749-6632.1991.tb27251.x. Ann N Y Acad Sci. 1991. PMID: 2006792 Review.

5

Chemotherapy of advanced ovarian cancer with 4'-O-tetrahydropyranyl doxorubicin and cisplatin: a randomized phase II trial with an evaluation of circadian timing and dose-intensity.

Lévi F, Benavides M, Chevelle C, Le Saunier F, Bailleul F, Misset JL, Regensberg C, Vannetzel JM, Reinberg A, Mathé G. Lévi F, et al. J Clin Oncol. 1990 Apr;8(4):705-14. doi: 10.1200/JCO.1990.8.4.705. J Clin Oncol. 1990. PMID: 2179481 Clinical Trial.

6

Circadian rhythms of tumor markers in breast cancer patients.

Touitou Y, Bailleul F, Lévi F, Bogdan A, Touitou C, Metzger G, Mechkouri M. Touitou Y, et al. Among authors: levi f. Prog Clin Biol Res. 1990;341A:59-66. Prog Clin Biol Res. 1990. PMID: 2217278 Clinical Trial. No abstract available.

7

Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate.

Caussanel JP, Lévi F, Brienza S, Misset JL, Itzhaki M, Adam R, Milano G, Hecquet B, Mathé G. Caussanel JP, et al. Among authors: levi f. J Natl Cancer Inst. 1990 Jun 20;82(12):1046-50. doi: 10.1093/jnci/82.12.1046. J Natl Cancer Inst. 1990. PMID: 2348469 Clinical Trial.

8

Circadian rhythm in toxicities and tissue uptake of 1,2-diamminocyclohexane(trans-1)oxalatoplatinum(II) in mice.

Boughattas NA, Lévi F, Fournier C, Lemaigre G, Roulon A, Hecquet B, Mathé G, Reinberg A. Boughattas NA, et al. Among authors: levi f. Cancer Res. 1989 Jun 15;49(12):3362-8. Cancer Res. 1989. PMID: 2720689

9

Timing of maintenance chemotherapy for childhood acute lymphoblastic leukaemia.

Lévi F, Bailleul F, Misset JL, Reinberg A, Mathe G. Lévi F, et al. Lancet. 1986 May 17;1(8490):1160-1. doi: 10.1016/s0140-6736(86)91877-5. Lancet. 1986. PMID: 2871414 No abstract available.

10

Circadian rhythm-varying plasma concentration of 5-fluorouracil during a five-day continuous venous infusion at a constant rate in cancer patients.

Petit E, Milano G, Lévi F, Thyss A, Bailleul F, Schneider M. Petit E, et al. Among authors: levi f. Cancer Res. 1988 Mar 15;48(6):1676-9. Cancer Res. 1988. PMID: 3345535

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

963 results

Search Page

Filters